ʻO Fulvestrant (ICI 182780) CAS 129453-61-8 API Hale Hana Kūlana Kiʻekiʻe
Hāʻawi Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Ka inoa: Fulvestrant
CAS: 129453-61-8
Hoʻohana ʻia ʻo Fulvestrant i ka mālama ʻana i ka maʻi maʻi umauma maʻi hormone-sensitive i nā wahine postmenopausal.
API no ke kūlana kiʻekiʻe, hana kālepa
Inoa Kimia | Fulvestrant |
Nā huaʻōlelo like | (7α,17β)-7-[9-[(4,4,5,5,5-Pentafluorpentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3,17-diol;ICI 182780 |
Helu CAS | 129453-61-8 |
Helu CAT | RF-API81 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram |
ʻĀpana Molekala | C32H47F5O3S |
Kaumaha Molecular | 606.77 |
Lae hehee | 104.0~106.0 ℃ |
Ka hikiwawe | Hiki ke hoʻoheheʻe ʻia i ka Methanol, Ethanol;ʻAʻole hiki ke hoʻonā i ka wai |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Keʻokeʻo a i ka pauka kristal keʻokeʻo |
ʻIkepili | Na IR, HPLC |
Hoʻololi Optical kikoʻī | +108.0° a i +115.0° |
Nalo ma ka maloo | ≤0.50% |
Koena ma ka Ignition | ≤0.10% |
6-Keto-Fulvestrant | ≤0.10% |
6,7-Fulvestrant | ≤0.10% |
ʻO Fulvestrant Sulfone | ≤0.20% |
Hoʻonui ʻia ʻo Fulvestrant | ≤0.30% |
ʻO Fulvestrant Sterol Dimmer | ≤0.80% |
ʻO kēlā me kēia kanaka ka haumia ʻole i hōʻike ʻia | ≤0.10% |
Huina paumaele | ≤1.0% |
ʻO Fulvestrant A | 42.0%~48.0% |
ʻO Fulvestrant B | 52.0%~58.0% |
DMF | ≤620ppm |
Nā Metala Kaumaha | ≤10ppm |
Hoʻāʻo | 97.0%~102.0% (ma ke kumu maloʻo) |
Waihona | E mālama ʻia i loko o kahi hale kūʻai i paʻa pono i ka mālamalama-kū ʻole i loko o ka friji ma 2 ~ 8 ℃ |
Kūlana hoʻāʻo | ʻAmelika Hui Pū ʻIa Pharmacopoeia (USP). |
Hoʻohana | Estrogen Receptor Antagonist |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.
ʻO Fulvestrant (ICI-182780) CAS 129453-61-8, he lāʻau hōʻoki ʻiʻo i hoʻomohala ʻia e ka hui ʻo AstraZeneca a hoʻohana ʻia i ka mālama ʻana i ka maʻi maʻi umauma maʻi maʻi hormone-sensitive i nā wahine postmenopausal.ʻO Fulvestrant wale nō ka lāʻau antiestrogen hiki ke hoʻohana nui ʻia ma hope o ka mālama ʻana i ka tamoxifen.ʻO kēia lāʻau lapaʻau he ʻano o ka endocrine therapy, no laila ʻaʻole ia e hoʻoulu i nā hopena ʻino i ʻike pinepine ʻia i ka chemotherapy, e hāʻawi ana i ka hoʻokō hoʻomanawanui maikaʻi.Ua ʻike ʻia nā hoʻokolohua lapaʻau he nui i ka 250mg Fulvestrant ka maikaʻi a me ka palekana mau ma ke ʻano he laina ʻelua o ka mālama ʻana no ka maʻi maʻi umauma kiʻekiʻe.ʻO Fulvestrant kahi mea hoʻohālikelike Estrogen Receptor (ER) Antagonist me IC50 o 0.94 nM i kahi hoʻāʻo ʻole kelepona.Hoʻokomo pū ʻo Fulvestrant i ka autophagy a me ka apoptosis a he hana antitumor.